menu search

Why shares of crispr therapeutics jumped thursday

CRISPR and Vertex Pharmaceuticals are jointly developing a gene-editing therapy to treat sickle cell disease and tranfusion-dependent beta thalassemia...

April 13, 2023, 11:58 am

Aeglea (agle) plunges 26% after rare disorder drug study fails

Aeglea BioTherapeutics (AGLE) announces failure to meet goals in the phase I/II study of pegtarviliase ...

April 13, 2023, 11:25 am

Tonix pharmaceuticals expedites fibromyalgia and chronic migraine programs

Streamlining phase 3 Fibromyalgia and phase 2 Chronic Mi...

April 13, 2023, 11:00 am

Tiziana life sciences plans to investigate intranasal foralumab for the treatment of long covid

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced plans to investigate intranasal foralumab for the treatment of Long COVID, work which is support...

April 13, 2023, 7:58 am

Enphase energy: ample meat for the bulls

We highlight some of the attractive aspects of the ENPH model. Forward valuations look attractive given the earnings potential....

April 13, 2023, 7:45 am

Regeneron: new highs following dupixent's copd data

Shares of Regeneron jumped to new all-time highs following the successful phase 3 results of Dupixent i...

April 13, 2023, 6:12 am

Ibm weighing sale of weather business: wsj

International Business Machines Corp. IBM is considering selling its weather operation, the Wall Street Journal reported on Wednesday. An auction for ...

April 12, 2023, 5:59 pm

Nokia: still connecting people but very differently than before

Great FY2022 results show that the new management and the three-phase plan are working well. The compan...

April 12, 2023, 2:11 pm

Why enphase energy (enph) is poised to beat earnings estimates again

Enphase Energy (ENPH) has an impressive earnings surprise history and currently possesses the right com...

April 12, 2023, 1:42 pm

Annovis: making sense of the interim analysis

Investor confusion surrounding Annovis's interim analysis of its phase 3 Parkinson's (PD) study highlig...

April 12, 2023, 1:13 pm

Prokidney: too many billionaires, too little data

ProKidney Corp. has a noble goal - ending kidney dysfunction using cell therapy. It has produced some interesting data from a ...

April 12, 2023, 11:51 am

X4 pharmaceuticals shares lift as investors await new data from whim syndrome study

X4 Pharmaceuticals, the Boston-based drug developer, saw its stock trading higher on Wednesday as investors gear up for new results from a ...

April 12, 2023, 10:58 am

Merck shares fall after us fda halts new patient enrollment of ms drug candidate trials

The US Food and Drug Administration has hit pause on patient enrollment for German drugmaker Merck's multiple sclerosis drug candidate evobrutinib aft...

April 12, 2023, 9:38 am

Aerovate: small mid-stage biotech targeting multibillion-dollar pah market

AVTE reported Q4 2023 earnings in line with expectations and has enough cash runway until H2 2025. AV-101, AVTE's lead asset, is on track with patient...

April 12, 2023, 8:45 am

Immupharma rises 4% after it reveals headway with lead asset

Shares of ImmuPharma PLC (AIM:IMM, OTC:IMMPF) rose 4% to 2.33p following news of progress in the development of a second indication for its lead asset...

April 12, 2023, 8:42 am

Calliditas therapeutics: good long-term data could boost tarpeyo sales

Calliditas Therapeutics recently reported positive long-term data of Tarpeyo (Nefecon/budesonide) in patients with IgA nephropathy. The results confir...

April 12, 2023, 6:34 am

Immupharma makes progress developing second indication for lead asset

ImmuPharma PLC (AIM:IMM, OTC:IMMPF) said the US Food & Drug Administration (FDA) has called a pre-investigational new drug (IND) meeting for May 16,�...

April 12, 2023, 2:40 am

Alphabet's capitalg backs ai market intelligence platform

AlphaSense CEO Jack Kokko joins Caroline Hyde and Ed Ludlow to discuss how Alphabet's independent growth fund CapitalG led a $100M round in the AI-dri...

April 11, 2023, 3:05 pm

Nano dimension prints growth: enters hypergrowth phase

The 3-D printing market has been slow to take hold, but it is taking hold, and Nano Dimension (NASDAQ: NNDM) is capitalizing on the event. The company...

April 11, 2023, 1:51 pm

Equity metals commences drilling on silver queen project in british columbia

Equity Metals Corporation (TSX-V:EQTY, OTCQB:EQMEF) has announced that crews have mobilized and drilling has commenced on its 100% owned Silver Quee...

April 11, 2023, 1:49 pm


Search within

Pages Search Results: